Yujiro Hata | Chief Executive Officer & President |
Matt Maurer | Head, Clinical Oncology |
Michael White | Chief Scientific Officer |
Paul Stone | Chief Financial Officer |
Anupam Rama | JPMorgan |
Maury Raycroft | Jefferies |
Charles Zhu | Guggenheim Securities |
Joel Beatty | RW Baird |
Ben Burnett | Stifel |
Tim Chiang | Northland Securities |
Zegbeh Jallah | Roth Capital Partners |
Good day and welcome to the IDEAYA Biosciences IDE397 Preliminary Clinical Data Update Conference Call. Today’s conference is being recorded. At this time, I would like to turn the call over to Yujiro Hata, CEO, IDEAYA Biosciences. Please go ahead
Good morning, everyone.